- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a product name.
BioCentury | Apr 20, 2023
Finance
April 20 Quick Takes: Hasten prepares for acquisitions with $315M raise
Plus: BMS, Tubulis partner and updates from BeiGene, Day One and Enveda
BioCentury | Mar 16, 2018
Emerging Company Profile
Cirius safety
How Cirius’ insulin sensitizer could avoid AEs of Actos, Avandia in NASH
BioCentury | Mar 15, 2018
Emerging Company Profile
Stabilizing damaged goods
How Methuselah is patching up damaged proteins to treat aging-related diseases
BioCentury | Oct 5, 2017
Strategy
Fixing FDA’s FAERS
FAERS is an underexploited but undercurated resource for de-risking tox
BioCentury | Oct 19, 2015
Finance
From Actos to act two
Why blood-brain penetration data convinced Ysios to lead Minoryx's series A
Items per page:
1 - 10 of 367